Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Federico Grossi
Age : 46
Public asset : 3,326,337 USD
Country of residence : Unknown
Linked companies : Apellis Pharmaceuticals, Inc.

Biography of Federico Grossi 
Federico Grossi occupies the position of Chief Medical Officer for Apellis Pharmaceuticals, Inc. He is also on the board of Endoprotech, Inc. In the past Dr. Grossi was Director-Clinical Research at Potentia Pharmaceuticals, Inc., Executive Vice President for Potentia Pharmaceuticals, Inc. and Member-Face Transplant Team at the University of Louisville. He received a graduate degree and a doctorate from the University of Louisville and a doctorate from National University of Cordoba.

Current positions of Federico Grossi 
Holdings of Federico Grossi 
Federico Grossi : Personal Network 
Most Read News 
01/04ELON MUSK : Musk-backed Starlink to refund pre-orders in India after govt order
01/11JAMIE DIMON : JPMorgan's Dimon says consumer loan growth may take 6-9 months to return to normal
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
01/10BRUNELLO CUCINELLI : Luxury group Cucinelli posts 31% sales jump in 2021
01/11CATHIE WOOD : ARK's Wood turns focus to deflation, 'stay connected' stocks
01/12MARTIN SORRELL : Sorrell's S4 says trading well ahead of guidance
01/13AMANCIO ORTEGA : Inditex founder Amancio Ortega buys Toronto's Royal Bank Plaza for $916 mln
01/07RICHARD BRANSON : British tycoon Branson to list blank-check firm in Amsterdam, Sky News says
01/07TIM COOK : Tim Cook earned over 1,400 times the average Apple worker in 2021
More news

© 2022 People and Ownership :   
Federico Grossi : Connections 

Latest news about Federico Grossi 
2021INSIDER TRENDS : Apellis Pharmaceuticals Insider Extends 90-Day Selling Trend
2020Swedish Orphan Biovitrum AB and Apellis Pharmaceuticals Inc. Reports Positive Top-Line Results At 48 Weeks from the Phase 3 Pegasus Study of Pegcetacoplan in PNH
2019ATS Automation Tooling Systems Inc. completed the acquisition of COMECER S.P.A. from Zanelli family and Principia III- Health Fund managed by Principia Società Di Gestione Del Risparmio S.P.A.
2018ATS Automation Tooling Systems Inc. entered into a definitive agreement to acquire COMECER S.P.A. from Zanelli family and Principia III- Health Fund managed by Principia Società Di Gestione Del Risparmio S.P.A. for approximately Ç110 million.
More news